| Category: | Health, |
|---|---|
| Address: | 116 Research Dr, Bethlehem, PA 18015, USA |
| Postal code: | 18015 |
| Phone: | (848) 702-0682 |
| Website: | http://levoltapharma.com/ |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Levolta Pharmaceuticals, use the form below and your opinion, advice or comment will appear in this space.
Levolta Pharmaceuticals. Surpassing current treatment barriers by developing products with an enhanced therapeutic index that drive customer value. 10.30.14 Levolta Pharmaceuticals Receives U.S. Patent for Novel Investigational Therapy for Controlling Osteoarthritis.
Levolta Pharmaceuticals. 116 Research Dr., Bethlehem, PA 18015 (848) 702-0682 rbecker@levoltapharma.com.
See more information about Levolta Pharmaceuticals, Inc., find and apply to jobs that match your skills, and connect with people to advance your career. VOLT01 has the potential to be the first Disease-Modifying Drug (DMARD) for osteoarthritis. For more information, please call (848) 702-0682...
Levolta Pharmaceuticals, Inc. company research & investing information. Levolta Pharmaceuticals, Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. Founded in 2013. Phone: 848-702-0682.
Levolta Pharmaceuticals's top competitors are Ionis Pharmaceuticals, Formula Pharmaceuticals and Saladax. See Levolta Pharmaceuticals's revenue, employees, and funding info on Owler, the world's largest community-based business insights platform.
Get directions, reviews and information for Levolta Pharmaceuticals in Bethlehem, PA. 116 Research Dr Bethlehem PA 18015. Reviews. (848) 702-0682 Website.
Levolta Pharmaceuticals, Inc. Based in Bethlehem, Pa., Levolta Pharmaceuticals features a portfolio of early-stage small molecules and late-stage novel formulated compounds for rheumatology, the central nervous system, oncology and immunology, which the company obtained through the...
Oct 30, 2014 · Formerly known as Voltarra Pharmaceuticals, Levolta's patent claims methods for treating osteoarthritis by intravenously administering a combination of prednisolone, or a pharmaceutically acceptable salt For more information, please call (848) 702-0682 or visit www.levoltapharma.com.
Levolta is currently focused on the commercialization of its complexed curcumin, VOLT03, which will be the only pharmaceutical-grade curcumin with an enhanced therapeutic index 3 Curcumin (diferuloylmethane) Richard Becker, CEO Levolta Pharmaceuticals [email protected] 848.702.0682.
Levolta is currently focused on the development of its lead product, VOLT01, which will be the first approved therapy that treats osteoarthritis disease. + Richard Becker, CEO Levolta Pharmaceuticals Rbecker@levoltapharma.com 848.702.0682.